Vaccines for youngest kids a step closer in US
COVID-19 vaccinations for the youngest children just might be a step closer. Moderna intends to seek U.S. authorization for kid-sized shots, releasing early study results Wednesday that suggest the two small doses work in tots younger than 6. Within weeks, competitor Pfizer hopes to learn if three of its even lower-dose shots do, too. Here’s what is known so far, and what’s next before the nation’s 18 million children under 5 can become eligible for vaccination. MODERNA’S RESULTS Moderna says tots as young as 6 months developed high levels of virus-fighting antibodies ...